Loading…
Sabra Health Care REIT, Inc. is projected to rise to $24.63 by 2027, a +16% move from its current price of $21.32. SBRA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $21.00 | $21.32 | $21.64 | -0.01% |
| Aug 2 | $20.87 | $21.31 | $21.77 | -0.02% |
| Aug 3 | $20.77 | $21.31 | $21.87 | -0.04% |
| Aug 4 | $20.68 | $21.31 | $21.96 | -0.05% |
| Aug 5 | $20.61 | $21.31 | $22.03 | -0.06% |
| Aug 6 | $20.54 | $21.30 | $22.10 | -0.07% |
| Aug 7 | $20.48 | $21.30 | $22.16 | -0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $20.48 | $21.30 | $22.16 | -0.09% |
| Week 2 | $20.13 | $21.28 | $22.51 | -0.17% |
| Week 3 | $19.86 | $21.27 | $22.77 | -0.25% |
| Week 4 | $19.63 | $21.25 | $23.00 | -0.34% |
| Week 5 | $19.43 | $21.23 | $23.19 | -0.42% |
| Week 6 | $19.25 | $21.21 | $23.37 | -0.51% |
| Week 7 | $19.09 | $21.19 | $23.53 | -0.59% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. It is incorporated on May 10th, 2010 and is based in Tustin, United States.
The stock is categorized in Real Estate and trades under the SBRA symbol.
Sabra Health Care REIT, Inc. focuses on healthcare-related real estate investments across North America, aligning with its healthcare sector mandate. The company is listed as a real estate asset with operations and governance anchored in its self-administered structure and U.S. headquarters.
Sabra Health Care REIT, Inc. is currently priced at $22.04 and carries a market cap of $5.56B. It ranks 1286 in market capitalization among publicly traded entities. The price outlook from the available forecast shows upside potential, with the average price rising over time—from $22.04 in 2026 to higher levels in later years—driven by bullish sentiment from 2028 onward.
Notably, the forecast pathway indicates 2030 an average price of $33.37 (max $45.46) and a 2050 average near $178.21 (max $291.33), suggesting substantial long-term appreciation potential alongside higher possible returns for later periods. While near-term momentum is mixed, the longer horizon portrays a strong bullish trajectory with rising averages and sizable ROIs.
A major floor 23.8% below — a decisive break under it would weaken the trend.
The nearest floor, 15.3% below — buyers have tended to step in here.
The nearest ceiling, 5.0% above — a clean break opens room to run.
A major ceiling 16.9% above — clearing it would confirm fresh momentum.
Key SBRA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SBRA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $22.08 | Sell | $21.81 | Sell |
| MA 10 | $21.65 | Sell | $21.56 | Sell |
| MA 20 | $20.76 | Buy | $20.97 | Buy |
| MA 50 | $19.84 | Buy | $20.29 | Buy |
| MA 100 | $20.08 | Buy | $20.01 | Buy |
| MA 200 | $19.54 | Buy | $19.59 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.60 | Neutral |
| Stoch RSI (14) | 29.21 | Neutral |
| CCI (20) | 36.05 | Neutral |
| Williams %R (14) | -37.28 | Info |
| MACD (12,26,9) | 0.11 | Buy |
| ROC (12) | 7.95 | Buy |
| Bollinger %B (20,2) | 0.63 | Neutral |
| Stochastic %K (14) | 62.72 | Neutral |
| TRIX (15) | 0.43 | Buy |
| Awesome (5,34) | 2.10 | Buy |
| Ultimate (7,14,28) | 44.58 | Neutral |
| Momentum (10) | 1.16 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 22.09 | Sell |
| ADX (14) | 26.60 | Buy |
| ATR (14) | 0.31 | Info |
The 30-day technical picture reads BULLISH, with RSI(14) at 70, signaling strong momentum. The 50-day simple moving average sits at $19.68 and the 200-day simple moving average at $19.40, placing the price above both averages on a short-term basis.
Key nearby levels include a support of $18.05 and a resistance of $22.04. The 30-day price range spans from $19.85 to $24.47, illustrating a window of near-term volatility within which the asset has recently traded.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $17.67 | $21.32 | $26.69 | 0% | Neutral | |
| $20.20 | $24.63 | $31.39 | +16% | Neutral | |
| $21.14 | $26.27 | $34.40 | +23% | Bullish | |
| $22.55 | $28.47 | $38.08 | +34% | Bullish | |
| $25.01 | $32.00 | $43.58 | +50% | Bullish | |
| $30.73 | $39.79 | $55.05 | +87% | Bullish | |
| $34.30 | $44.92 | $63.04 | +111% | Bullish | |
| $35.22 | $46.61 | $66.26 | +119% | Bullish | |
| $38.64 | $51.65 | $74.31 | +142% | Bullish | |
| $39.65 | $53.51 | $77.84 | +151% | Bullish | |
| $61.50 | $86.57 | $131.99 | +306% | Bullish | |
| $115.80 | $174.82 | $285.75 | +720% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $17.67 | $21.32 | $24.83 | +0.00% |
| August 2026 | $18.13 | $21.14 | $25.12 | -0.83% |
| September 2026 | $17.98 | $21.09 | $25.29 | -0.27% |
| October 2026 | $18.41 | $21.69 | $26.21 | +2.86% |
| November 2026 | $18.60 | $21.99 | $26.73 | +1.40% |
| December 2026 | $18.40 | $21.83 | $26.69 | -0.72% |
Click any year to see its month-by-month SBRA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The SBRA price prediction for 2026 points to an average of $21.32 (low $17.67, high $26.69) — a potential gain of 0% on today's $21.32. A consolidation phase looks the most probable path here.
In 2027, SBRA is projected to trade between $20.20 and $31.39, averaging $24.63 — a potential gain of +16% from today's $21.32. That is up +16% on the projected 2026 average. Price action looks broadly range-bound.
Sabra Health Care REIT, Inc.'s 2028 outlook centres on $26.27, within a $21.14 to $34.40 range. That is up +7% on the projected 2027 average. That marks a +23% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, SBRA could reach as high as $38.08, with a base case around $28.47 and support toward $22.55 — roughly +34% from $21.32. Momentum favours further upside here.
Expect SBRA to range from $25.01 to $43.58 through 2030. The $32.00 average target implies a +50% move from current prices. That is up +12% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The SBRA price prediction for 2031 points to an average of $39.79 (low $30.73, high $55.05) — a potential gain of +87% on today's $21.32. Momentum favours further upside here.
In 2032, SBRA is projected to trade between $34.30 and $63.04, averaging $44.92 — a potential gain of +111% from today's $21.32. That is up +13% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Sabra Health Care REIT, Inc.'s 2033 outlook centres on $46.61, within a $35.22 to $66.26 range. That is up +4% on the projected 2032 average. That marks a +119% change versus current levels. Momentum favours further upside here.
By 2034, SBRA could reach as high as $74.31, with a base case around $51.65 and support toward $38.64 — roughly +142% from $21.32. Buyers look set to stay in control over this stretch.
Expect SBRA to range from $39.65 to $77.84 through 2035. The $53.51 average target implies a +151% move from current prices. That is up +4% on the projected 2034 average. Momentum favours further upside here.
The SBRA price prediction for 2040 points to an average of $86.57 (low $61.50, high $131.99) — a potential gain of +306% on today's $21.32. Buyers look set to stay in control over this stretch.
In 2050, SBRA is projected to trade between $115.80 and $285.75, averaging $174.82 — a potential gain of +720% from today's $21.32. That is up +102% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in SBRA today (≈ 46.904315 SBRA) could be worth
$8,199.79
+$7,199.79 (+720%) by 2050 · US Dollar
Based on the average projected SBRA price of $174.82 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SBRAwould be worth at today's price.
$1,000 invested in SBRA on Jul 30, 2025 (≈ 55.67929 SBRA) would be worth
$1,187.08
+$187.08 (+18.7%) today · 1.19× · US Dollar
Based on a SBRA entry price of $17.96 vs. today's $21.32.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $22.03 | $967.77 | -3.2% |
| 1 month ago | $19.51 | $1,092.77 | +9.3% |
| 3 months ago | $20.36 | $1,047.15 | +4.7% |
| 6 months ago | $18.73 | $1,138.28 | +13.8% |
| 1 year ago | $17.96 | $1,187.08 | +18.7% |
| All time (5.0y) ago | $18.6 | $1,146.24 | +14.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SBRA forecast.
Our base-case forecast reaches $43.00 around 2032.
Implied market cap at $43.00: $10.84B
Over the multi-year forecast horizon, Sabra Health Care REIT, Inc. shows meaningful upside. The 2026 forecast centers around a 2026 avg of $22.04 with a neutral sentiment and a 0% ROI, then progresses to 2027 avg $25.67 (ROI 16.5%), 2028 avg $26.89 (ROI 22%), and 2029 avg $29.26 (ROI 32.8%).
The path accelerates toward 2030, where the avg price is forecast at $33.37 with a 51.4% ROI, followed by continued gains through 2031–2035 and well into 2040 and 2050. By 2040, the avg is $87.70 (ROI 297.9%), and by 2050 the avg reaches $178.21 (ROI 708.6%), with bullish sentiment prevailing.
These projections imply a sustained upward trajectory and substantial long-term upside, but they are estimates, not guarantees. The forecast includes a broad range of potential outcomes and reflects varying yearly momentum across the period, alongside inherent market volatility (annualized volatility about 30%).
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $33.37 with a max of $45.46 and a min of $26.07, for an ROI of 51.4%, and a bullish sentiment. This indicates significant upside relative to current levels, though it is not a guarantee.
Forecasts show upside over time, with 2030–2050 avg prices trending higher (e.g., $33.37 by 2030 and $178.21 by 2050) and substantial ROIs (e.g., 51.4% in 2030, 708.6% by 2050). However, forecasts are estimates, not guarantees, and near-term risk and volatility exist.
Yes. The forecast includes a 2040 max of $133.75 and a 2050 max of $291.33, indicating that reaching $100 is within the projected range over the longer term.
For 2026, the min is $17.67, the avg is $22.04, the max is $27.64, with an ROI of 0 and a Neutral sentiment.
Forecasts are not guarantees and reflect a wide range of possible outcomes. The data show substantial upside potential (e.g., 2050 max $291.33) but also volatility and sensitivity to market conditions, with an annualized volatility of about 30% cited in the inputs.
Sabra Health Care REIT, Inc. Community Discussion
0Share your Sabra Health Care REIT, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.